These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12602917)

  • 1. Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and vinorelbine in metastatic breast cancer.
    Rimassa L; Carnaghi C; Garassino I; Salvini P; Ginanni V; Gullo G; Morenghi E; Santoro A
    Breast Cancer Res Treat; 2003 Jan; 77(2):185-8. PubMed ID: 12602917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation.
    Gebbia V; Mauceri G; Fallica G; Borsellino N; Tirrito ML; Testa A; Varvara F; Colombo A; Ferrera P
    Oncology; 2002; 63(1):23-30. PubMed ID: 12187067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
    Ardavanis A; Mavroudis D; Kalbakis K; Malamos N; Syrigos K; Vamvakas L; Kotsakis A; Kentepozidis N; Kouroussis C; Agelaki S; Georgoulias V;
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):742-8. PubMed ID: 16718470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
    Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
    Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of Doxil and vinorelbine in metastatic breast cancer.
    Burstein HJ; Ramirez MJ; Petros WP; Clarke KD; Warmuth MA; Marcom PK; Matulonis UA; Parker LM; Harris LN; Winer EP
    Ann Oncol; 1999 Sep; 10(9):1113-6. PubMed ID: 10572612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
    Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
    Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinoma.
    Pawlicki M; Rolski J; Zaluski J; Siedlecki P; Ramlau C; Tomzak P
    Oncologist; 2002; 7(3):205-9. PubMed ID: 12065792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer.
    Hegg R; Costa MA; Perdicaris M; Delgado GL; Cabral-Filho S; Malzyner A; Caponero R; Yamagushi N; Novaes N; Anelli A; Correa M; Nader L; Andrade C
    Curr Med Res Opin; 2001; 16(4):225-34. PubMed ID: 11268706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated liposomal doxorubicin (Caelyx®) and oral vinorelbine in first-line metastatic breast cancer patients previously treated with anthracyclines.
    Livi L; Meattini I; Scotti V; De Luca Cardillo C; Galardi A; Iermano C; Sanchez L; Nori J; Mangoni M; Franzese C; Orzalesi L; Bertocci S; Agresti B; Masoni T; Bianchi S; Cataliotti L; Biti G
    J Chemother; 2011 Jun; 23(3):158-62. PubMed ID: 21742585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of paclitaxel combined with vinorelbine in patients with advanced breast cancer.
    Spano JP; Bouillet T; Boaziz C; Piperno-Neumann S; Brunel P; Hennebelle F; Amsalhem P; Brunet-Pommeyrol A; Kanoui A; Morin F; Breau JL; Morere JF
    Am J Clin Oncol; 2004 Jun; 27(3):317-21. PubMed ID: 15170156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer.
    Shamseddine AI; Taher A; Dabaja B; Dandashi A; Salem Z; El Saghir NS
    Am J Clin Oncol; 1999 Jun; 22(3):298-302. PubMed ID: 10362341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
    Mlineritsch B; Schabel-Moser R; Andel J; Fridrik M; Moik M; Mayer P; Russ G; Rass C; Greil R;
    Onkologie; 2009 Feb; 32(1-2):18-24. PubMed ID: 19209014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
    Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
    Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D
    Clin Breast Cancer; 2006 Feb; 6(6):511-7. PubMed ID: 16595034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/ relapsed metastatic breast cancer.
    Airoldi M; Cattel L; Pedani F; Marchionatti S; Tagini V; Bumma C; Recalenda V
    Acta Oncol; 2003; 42(3):186-94. PubMed ID: 12852694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of vinorelbine + doxorubicin in advanced breast cancer.
    Lorvidhaya V; Kamnerdsupaphon P; Chitapanarux I; Srisukho S; Trakultivakorn H; Sumitsawan S; Sukthomya V; Tonusin A
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1131-8. PubMed ID: 12938268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.
    Keller AM; Mennel RG; Georgoulias VA; Nabholtz JM; Erazo A; Lluch A; Vogel CL; Kaufmann M; von Minckwitz G; Henderson IC; Mellars L; Alland L; Tendler C
    J Clin Oncol; 2004 Oct; 22(19):3893-901. PubMed ID: 15459210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal-encapsulated doxorubicin (Myocet; D-99) and vinorelbine in previously treated metastatic breast cancer patients: a feasibility study.
    Poletti P; Bettini AC; Caremoli ER; Labianca R; Tondini C
    Tumori; 2008; 94(5):686-90. PubMed ID: 19112941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer: a stratified phase II study.
    Hochster HS; Vogel CL; Burman SL; White R
    Oncologist; 2001; 6(3):269-77. PubMed ID: 11423674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
    Farhat F; Kattan JG; Ghosn M
    Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.